Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stoke Therapeutics (STOK) Amortizatization of Intangibles: 2021-2024

Historic Amortizatization of Intangibles for Stoke Therapeutics (STOK) over the last 4 years, with Dec 2024 value amounting to -$1.6 million.

  • Stoke Therapeutics' Amortizatization of Intangibles fell 12.43% to -$615,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.4 million, marking a year-over-year decrease of 43.73%. This contributed to the annual value of -$1.6 million for FY2024, which is 405.23% down from last year.
  • According to the latest figures from FY2024, Stoke Therapeutics' Amortizatization of Intangibles is -$1.6 million, which was down 405.23% from -$325,000 recorded in FY2023.
  • In the past 5 years, Stoke Therapeutics' Amortizatization of Intangibles ranged from a high of $143,000 in FY2021 and a low of -$1.6 million during FY2024.
  • Its 3-year average for Amortizatization of Intangibles is -$726,000, with a median of -$325,000 in 2023.
  • Data for Stoke Therapeutics' Amortizatization of Intangibles shows a maximum YoY plummeted of 405.23% (in 2024) over the last 5 years.
  • Yearly analysis of 4 years shows Stoke Therapeutics' Amortizatization of Intangibles stood at $143,000 in 2021, then plummeted by 247.55% to -$211,000 in 2022, then tumbled by 54.03% to -$325,000 in 2023, then plummeted by 405.23% to -$1.6 million in 2024.